Sunday, April 10, 2022

Shanghai hospital pays the price for China's COVID response



from Yahoo News - Latest News & Headlines https://ift.tt/8b5ZKLj

No comments:

Post a Comment

FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001...